73 related articles for article (PubMed ID: 2449291)
21. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
[TBL] [Abstract][Full Text] [Related]
22. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
Hagner G
Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
[TBL] [Abstract][Full Text] [Related]
23. Role of vincristine in immunochemotherapy of leukemia in mouse or human models.
Prete SP; De Filippi R; Silvi E; Bartocci A; Giuliani A
Immunopharmacol Immunotoxicol; 1990; 12(1):135-57. PubMed ID: 2351791
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of the damaging effect of dermatomyositis mononuclear cells on cultured human skin fibroblasts.
Saito E; Kuroda K; Yoshimoto Y; Oshima H; Kinoshita M
J Rheumatol; 1989 Aug; 16(8):1055-60. PubMed ID: 2585402
[TBL] [Abstract][Full Text] [Related]
25. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
26. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
27. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
Mier JW; Brandon EP; Libby P; Janicka MW; Aronson FR
J Immunol; 1989 Oct; 143(7):2407-14. PubMed ID: 2528594
[TBL] [Abstract][Full Text] [Related]
28. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
Laskay T; Kiessling R
Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635
[TBL] [Abstract][Full Text] [Related]
29. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
30. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
Abrams SI; Brahmi Z
J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
Lee SH; Kelley S; Chiu H; Stebbing N
Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
[TBL] [Abstract][Full Text] [Related]
32. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
33. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types.
Sulica A; Gherman M; Manciulea M; Galatiuc C; Herberman RB
Nat Immun Cell Growth Regul; 1989; 8(5):266-78. PubMed ID: 2480519
[TBL] [Abstract][Full Text] [Related]
35. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
37. Studies on the intracellular Ca2+, protein kinase activity, and ATP contents of cisplatin- and rIFN-Y-treated non-adherent mononuclear cells.
Pai K; Sodhi A
Biochem Int; 1992 May; 26(6):1017-24. PubMed ID: 1632798
[TBL] [Abstract][Full Text] [Related]
38. Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations.
Franzese O; Tricarico M; Starace G; Pepponi R; Bonmassar L; Cottarelli A; Fuggetta MP
J Interferon Cytokine Res; 2013 Jun; 33(6):308-18. PubMed ID: 23421371
[TBL] [Abstract][Full Text] [Related]
39. In vitro combined effects of human interferons and interleukin-2 on natural cell-mediated cytotoxicity.
Fuggetta MP; Aquino A; Pepponi R; D'Atri S; Lanzilli G; Bonmassar E; Graziani G
Int J Immunopharmacol; 1993 Jan; 15(1):1-10. PubMed ID: 7679378
[TBL] [Abstract][Full Text] [Related]
40. Effect of 4-hydroxynonenal, a product of lipid peroxidation, on NK susceptibility of human K562 target cells.
Rinaldi M; Tricarico M; Bonmassar E; Parrella P; Barrera G; Fazio VM
Anticancer Res; 1998; 18(5A):3591-5. PubMed ID: 9858944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
